Skip to main content

Table 3 Distribution of treatment lines over the study years, mRCC patients, Estonia 2004–2012

From: Changes in therapy and survival of metastatic renal cell carcinoma in Estonia

 2004–2007200820092010201120122004–2012
Treatment lines
 First line154 (100)26 (100)50 (100)47 (100)58 (100)62 (100)397 (100)
 Second line6 (4)16 (62)21 (42)24 (51)24 (41)19 (31)110 (28)
 Third line0 (0)5 (19)8 (16)15 (32)18 (31)11 (18)57 (14)
 Fourth line0 (0)0 (0)2 (4)2 (4)3 (5)3 (5)10 (3)